D. Medical Industries (DMED)
D. Medical Industries Capital Expenditures: 0.00
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
DMED Capital Expenditures Rankings
| Overall | 99th percentile | 1 of 4450 |
| Sector | 99th percentile | 1 of 507 in Healthcare |
| Industry | 98th percentile | 1 of 64 in Medical Instruments & Supplies |
DMED Capital Expenditures Range, Past 5 Years
| Minimum | 0.00 | Mar 2009 |
| Maximum | 0.62M | Dec 2010 |
| Average | 0.07M |
About Capex
Capital expenditures are a line item from a company's statement of cash flows (click "Learn More" below for details).
Capex (short for capital expenditures) are incurred when a business spends money to purchase fixed assets or to add value to an existing fixed asset. In accounting, a capital expenditures are added to an asset account, thus increasing the value of the asset.
Examples of capital expenditures include the purchase of a new manufacturing plant, investment in server farms for tech companies, or other purchases of assets expected to help the company earn profits in the future.
Unlike other investments like research and development and marketing spending, capital expenditures are not immediately expensed. Rather, property, plant and equipment acquired using capital expenditures are usually expensed over time through the use of depreciation.
Learn More
You may also be interested in these DMED related companies
DMED News
D. Medical (DMED) Enters into OEM Agreement for Spring Universal DDI Sets
May 14, 7:48AM Street Insider
May 14, 7:48AM Street Insider
D. Medical Signs First Worldwide OEM Agreement for Spring Universal(TM) Detach Detect Infusion Sets
May 14, 7:45AM GlobeNewswire
May 14, 7:45AM GlobeNewswire
D. Medical Announces Availability of Its Annual Report on Form 20-F Through Its Website
Apr 30, 2:15PM GlobeNewswire
Apr 30, 2:15PM GlobeNewswire
D. Medical (DMED) Initiates Strategic Restructuring; Will Reduce Staff, Executive Compensation
Mar 22, 7:47AM Street Insider
Mar 22, 7:47AM Street Insider
D. Medical Receives NASDAQ Notification of Non-Compliance With Minimum Bid Price Rule
Mar 13, 10:45AM GlobeNewswire
Mar 13, 10:45AM GlobeNewswire
D. Medical Makes Strategic Changes to Its European Distribution Network for Its Spring Universal Infusion Sets
Feb 14, 8:15AM GlobeNewswire
Feb 14, 8:15AM GlobeNewswire
D. Medical Signs Fifth U.S. Distribution Agreement for Spring Universal Infusion Sets
Jan 25, 8:03AM Benzinga
Jan 25, 8:03AM Benzinga
Expansion of D. Medical's U.S. Distribution Network for Spring Universal Infusion Sets Continues
Jan 17, 8:10AM GlobeNewswire
Jan 17, 8:10AM GlobeNewswire
Spring Universal Infusion Set Listed in the 2012 Consumer Guide of the American Diabetes Association
Jan 04, 8:30AM GlobeNewswire
Jan 04, 8:30AM GlobeNewswire
Instructional Video Now Available for Evolutionary Spring Universal Infusion Set
Dec 26, 7:57AM GlobeNewswire
Dec 26, 7:57AM GlobeNewswire
D. Medical Further Expands U.S. Distribution Network for Spring Universal Infusion Sets
Dec 05, 7:45AM GlobeNewswire
Dec 05, 7:45AM GlobeNewswire
A 3-Year Supply of Spring Universal Infusion Set to be Donated to an Uninsured Family
Nov 13, 8:01AM GlobeNewswire
Nov 13, 8:01AM GlobeNewswire
D. Medical expands U.S. distribution network for Spring Universal infusion sets
Oct 06, 8:16AM FlyOnTheWall
Oct 06, 8:16AM FlyOnTheWall
D. Medical Initiates Strategic Restructuring; Includes Contemplated Staff Reduction
Sep 07, 9:32AM Benzinga
Sep 07, 9:32AM Benzinga
D. Medical to Present at the Rodman & Renshaw Annual Global Investment Conference
Sep 02, 9:07AM Marketwire
Sep 02, 9:07AM Marketwire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| DMED | 0.38 | +0.00 | +0.00% | 4.108M |
| DMD | 9.67 | +0.05 | +0.52% | 806.38M |
| DM | 6.84 | -0.03 | -0.44% | 209.17M |
| DLX | 22.88 | -0.10 | -0.44% | 1.165B |
| DLTR | 102.20 | +0.49 | +0.48% | 11.82B |
| DLS | 43.55 | -0.11 | -0.25% | |
| DLN | 50.66 | -0.11 | -0.22% | |
| DLLR | 15.52 | -0.03 | -0.19% | 684.90M |
| DIS | 44.50 | +0.06 | +0.14% | 79.76B |
| DIOD | 19.61 | +0.20 | +1.03% | 891.47M |
